| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.0M | -0.6% | -23.3% |
| Cost of Revenue | $4.5M | -18.8% | -28.9% |
| Gross Profit | $534K | +212.7% | +124.4% |
| R&D Expense | $828K | -7.0% | -24.9% |
| SG&A Expense | $3.5M | +15.0% | -50.0% |
| Operating Income | -$5.6M | +12.6% | +41.6% |
| Pre-tax Income | -$4.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $126.3M | -2.4% | -13.1% |
| Accounts Receivable | $4.4M | +27.0% | -9.2% |
| Inventory | $5.9M | -3.7% | -44.8% |
| Current Assets | $142.1M | -1.4% | -14.4% |
| Total Assets | $151.0M | -1.9% | -14.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.7M | — | — |
| Investing Cash Flow | -$607K | — | — |
| Financing Cash Flow | -$398K | — | — |
| +27.6% |
| +52.1% |
| Income Tax | -$847K | -906.7% | -335.3% |
| Net Income | -$3.5M | +42.9% | -104.0% |
| EPS (Basic) | -$0.15 | +42.3% | -104.1% |
| EPS (Diluted) | -$0.15 | +42.3% | -104.1% |
| $6.7M |
| +1.5% |
| -64.5% |
| Total Liabilities | $7.4M | -1.4% | -63.7% |
| Stockholders' Equity | $143.7M | -1.9% | -8.3% |